Higher 25-hydroxyvitamin D level is associated with increased risk for Behçet's disease.

Abstract

BACKGROUND & AIM:

Previous studies showed a vitamin D deficiency in patients with Behçet's disease, suggesting potential benefits of vitamin D supplementation in the prevention and treatment of Behçet's disease. Interpretation of these studies may be limited by reverse causality or confounding bias. We aim to determine the causal association between serum 25-hydroxyvitamin D [25(OH)D] and the risk of Behçet's disease by Mendelian randomization.

METHODS:

An allele score formed by four variants (rs2282679, rs10741657, rs12785878 and rs6013897) that were associated with serum 25(OH)D level, was examined using data of genome-wide association study (GWAS) on 999 Behçet's disease and 4417 healthy individuals of Chinese ancestry and validated using data of GWAS on 1215 Behçet's disease and 1278 controls of Turkish ancestry. The primary outcome was the risk of Behçet's disease, evaluated by an inverse variance weighted average of the associations with genetically determined 25(OH)D levels.

RESULTS:

The inverse variance weighted estimate showed that genetically increased 25(OH)D level was associated with a higher risk of Behçet's disease. In the Chinese cohort, the odds ratio for Behçet's disease in one standard deviation increase of natural log-transformed 25(OH)D level was 3.82 (95% CI: 1.27-11.42). Data from Turkish cohort confirmed the association with Behçet's disease (OR, 95% CI: 4.18, 1.15-15.12). In overall combination of Chinese and Turkish cohorts, the odds ratio for Behçet's disease per standard deviation increase of natural log-transformed 25(OH)D level was estimated to be 3.96 (95% CI: 1.72-9.13; P = 0.001). No significant evidence of pleiotropy and heterogeneity was detected.

CONCLUSIONS:

On the basis of evidence in 7909 human beings, this study provides the newest indication that a lifelong higher 25(OH)D level is associated with an increased risk of Behçet's disease. Special attention should be paid to the potential harm of long-term or high-dose use of vitamin D supplements in clinical practice.

• Authors: Zhenyu Zhong, Guannan Su, Liping Du, Qingyun Zhou, Fuzhen Li, Wei Chi, Shengyun Liu, Meifen Zhang, Xianbo Zuo, Peizeng Yang
• Journal: Clinical nutrition (Edinburgh, Scotland) (Clin Nutr) Vol. 40 Issue 2 Pg. 518-524 (02 2021) ISSN: 1532-1983 [Electronic] England
• PMID: 32593521 (Publication Type: Journal Article, Research Support, N.I.H., Intramural, Research Support, Non-U.S. Gov't)
• Copyright: Copyright © 2020 Elsevier Ltd and European Society for Clinical Nutrition and Metabolism. All rights reserved.

Chemical References

• Vitamin D
• 25-hydroxyvitamin D

Topics

• Alleles
• Asian People (genetics)
• Behcet Syndrome (blood, genetics)
• Case-Control Studies
• China (ethnology)
• Cohort Studies
• Genetic Predisposition to Disease (genetics)
• Genome-Wide Association Study
• Humans
• Linkage Disequilibrium
• Mendelian Randomization Analysis
• Odds Ratio
• Polymorphism, Single Nucleotide
• Risk Assessment
• Risk Factors
• Turkey (ethnology)
• Vitamin D (analogs & derivatives, blood)